Skip to main content

Table 1 Epidemiological and characterizing parameters

From: Clinical trial and in-vitro study comparing the efficacy of treating bony lesions with allografts versus synthetic or highly-processed xenogeneic bone grafts

  Allogenic cancellous bone (ACB) N Synthetic bone substitutes (SBS) N P
Age 62.6 ± 19.6 116 55.8 ± 16.3 116 0.004a
Gender (f/m) 62/54 116 55/61 116 n.s.b
ASA 2.31 ± 0.72 116 1.95 ± 0.67 116 <0.0001c
Defect size 20.21 ± 21.00 114 5.75 ± 8.33 115 <0.0001a
BMI 26.01 ± 5.15 116 26.99 ± 5.60 116 n.s.a
Consolidation time (months) 3.93 ± 2.45 104 3.16 ± 3.31 107 n.s.d
Complication rate 17 (14.6 %) 116 16 (13.8 %) 116 n.s.b
Healing rate 104 (89.7 %) 116 107 (92.2 %) 116 n.s.b
  1. Overview about the epidemiological and characterizing parameters comparing both intervention groups, f female, m male, ASA physical status according to the American Society of Anesthesiologists, BMI body mass index, n.s. – not significant, a t-Test, b χ 2-Test, c U-Test (Mann und Whitney), dAspin-Welch-Test